drugset / Trial / NCT00694252
Lapatinib and Circulating Tumor Cells in Breast Cancer
NaSingle-groupOpen-labelTreatment
Summary
This study will evaluate the efficacy of lapatinib in eradicating chemo- resistant tumour cells circulating in the blood of patients with breast cancer.
Timeline
- Start
- 2008-07
- Primary completion
- 2011-11
- Completion
- 2011-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lapatinib | Small molecule | 1500 mg | — |